TNF and inflammatory bowel disease: The pleiotropic proinflammatory cytokine tumor necrosis factor α (TNFα), performs a crucial role in the pathogenesis of CD and UC, and anti-TNFα agents were the first biological drugs approved to treat IBD [3].